Jci_page_head_homepage_01 Jci_page_head_homepage_02
Mihail G. Chelu, Satyam Sarma, Subeena Sood, Sufen Wang, Ralph J. van Oort, Darlene G. Skapura, Na Li, Marco Santonastasi, Frank Ulrich Müller, Wilhelm Schmitz, Ulrich Schotten, Mark E. Anderson, Miguel Valderrábano, Dobromir Dobrev, Xander H.T. Wehrens
Published in Volume 119, Issue 7
J Clin Invest. 2009; 119(7):1940–1951 doi:10.1172/JCI37059
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 4
Pharmacological inhibition of CaMKII reverses enhanced SR Ca2+ leak in Ryr2R176Q/+ atrial myocytes.

Representative [Ca2+]i recordings obtained from fluo-4 AM–loaded atrial myocytes from WT (A) and Ryr2R176Q/+ (B) mice during 1 Hz pacing in 1.8 mM Ca2+ (left), followed by a rapid switch to Tyrode solution containing 0 Na+, 0 Ca2+, and tetracaine (TTC) (1 mmol/l). Tetracaine was washed out 30 seconds later, and SR Ca2+ content was measured by changing superfusate to 10 mmol/l caffeine in 0 Na+, 0 Ca2+ Tyrode solution. SR Ca2+ leak was measured as shown in red and related to SR Ca2+ content. (C) Bar graph represents quantification of SR Ca2+ leak normalized to SR Ca2+ content in the presence and absence of KN-93 in WT and Ryr2R176Q/+ atrial myocytes. *P < 0.05. Numbers in bars indicate numbers of myocytes tested.